Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

被引：0
|
作者：
Diana Carmona-Fernandes
Maria José Santos
Inês Pedro Perpétuo
João Eurico Fonseca
Helena Canhão
机构：
[1] Instituto de Medicina Molecular,Rheumatology Research Unit
[2] Faculdade de Medicina da Universidade de Lisboa,Rheumatology Department
[3] Edifício Egas Moniz,Rheumatology and Bone Metabolic Diseases Department
[4] Hospital Garcia de Orta,undefined
[5] Hospital de Santa Maria,undefined
来源：
Arthritis Research & Therapy | / 13卷
关键词：
sRANKL; osteoprotegerin; systemic lupus erythematosus; osteoclastogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients
    Carmona-Fernandes, Diana
    Santos, Maria Jose
    Perpetuo, Ines Pedro
    Fonseca, Joao Eurico
    Canhao, Helena
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (05)
  • [2] Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis
    Grimaud, E
    Soubigou, L
    Couillaud, S
    Coipeau, P
    Moreau, A
    Passuti, N
    Gouin, F
    Redini, F
    Heymann, D
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05): : 2021 - 2031
  • [3] Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
    Tabari, Zahra Alizadeh
    Azadmehr, Abbas
    Tabrizi, Mohammad Amir Alizadeh
    Hamissi, Jalaloddin
    Ghaedi, Fatemeh Baharak
    JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE, 2013, 43 (05): : 227 - 232
  • [4] The osteoprotegerin/receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand system in cartilage
    Komuro, H
    Olee, T
    Kühn, K
    Quach, J
    Brinson, DC
    Shikhman, A
    Valbracht, J
    Creighton-Achermann, L
    Lotz, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2768 - 2776
  • [5] Osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in children with inflammatory bowel disease
    Jankowska, Agnieszka
    Gutowska-Owsiak, Danuta
    Kaminska, Barbara
    Liberek, Anna
    PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (03): : 191 - 196
  • [6] Osteoprotegerin and Ligand of Receptor Activator of Nuclear Factor
    Tan, Lijun
    Ren, Yijin
    Wang, Jun
    Jiang, Lingyong
    Cheng, Hui
    Sandham, Andrew
    Zhao, Zhihe
    ANGLE ORTHODONTIST, 2009, 79 (02) : 292 - 298
  • [7] Relationship of endothelial function with serum osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) in women with systemic lupus erythematosus (SLE).
    Rhew, Elisa Y.
    Lee, Chin
    Eksarko, Poli
    Chung, Anh
    Price, Heather E.
    Dyer, Alan R.
    Langman, Craig B.
    Pope, Richard M.
    McPherson, David D.
    Ramsey-Goldman, Rosalind
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S271 - S271
  • [8] Increased receptor activator of nuclear factor ligand/osteoprotegerin ratio exacerbates cartilage destruction in osteoarthritis in vitro
    Zeng, Ji-Zhou
    Wang, Zhen-Zhong
    Ma, Li-Feng
    Meng, Hai
    Yu, Hao-Miao
    Cheng, Wen-Hao
    Zhang, Ya-Kui
    Guo, Ai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (04) : 2778 - 2782
  • [9] Expression of Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor Kappa B Ligand in the Aortic Valve Calcification
    Voronkina, I. V.
    Irtyuga, O. B.
    Smagina, L., V
    Adamova, P. E.
    Zhiduleva, E., V
    Malashicheva, A. B.
    Sibagatullina, Y. S.
    Kruk, L. P.
    Gordeev, M. L.
    Moiseeva, O. M.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2019, 13 (02) : 173 - 178
  • [10] Expression of Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor Kappa B Ligand in the Aortic Valve Calcification
    I. V. Voronkina
    O. B. Irtyuga
    L. V. Smagina
    P. E. Adamova
    E. V. Zhiduleva
    A. B. Malashicheva
    Y. S. Sibagatullina
    L. P. Kruk
    M. L. Gordeev
    O. M. Moiseeva
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2019, 13 : 173 - 178
12345